We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+31.61%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$561M
AUM Growth
+$315M
Cap. Flow
+$248M
Cap. Flow %
44.2%
Top 10 Hldgs %
35.2%
Holding
112
New
30
Increased
42
Reduced
5
Closed
33

Top Buys

Rank Stock Value
1
RARE icon
Ultragenyx Pharmaceutical
RARE
+$16.6M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$12.9M
3
MDCO
Medicines Co
MDCO
+$12.8M
4
AMGN icon
Amgen
AMGN
+$12.7M
5
BIIB icon
Biogen
BIIB
+$12.6M

Top Sells

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$6.11M
2
HCA icon
HCA Healthcare
HCA
+$3.85M
3
ILMN icon
Illumina
ILMN
+$3.51M
4
ELV icon
Elevance Health
ELV
+$2.58M
5
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$2.02M

Sector Composition

Rank Sector Weight
1 Healthcare 73.05%
2 Energy 0.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KITE
51
DELISTED
Kite Pharma, Inc.
KITE
$3.35M 0.6%
60,000
+10,000
+20% +$557K
ISEE
52
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$3.23M 0.58%
+70,000
New +$3.95M
SRPT icon
53
Sarepta Therapeutics
SRPT
$1.93B
$3.07M 0.55%
+50,000
New +$1.51M
XENT
54
DELISTED
Intersect ENT, Inc
XENT
$2.85M 0.51%
180,000
+30,000
+20% +$452K
TNDM icon
55
Tandem Diabetes Care
TNDM
$1.6B
$2.83M 0.51%
37,000
+19,500
+111% +$1.42M
PMC
56
PUT
DELISTED
PharMerica Corporation
PMC
$2.81M 0.5%
+100,000
New +$2.56M
IVTY
57
DELISTED
Invuity, Inc
IVTY
$2.74M 0.49%
+200,000
New +$2.38M
ARRY
58
DELISTED
Array Biopharma Inc
ARRY
$2.7M 0.48%
+400,000
New +$1.55M
PACB icon
59
Pacific Biosciences
PACB
$333M
$2.69M 0.48%
300,000
+200,000
+200% +$1.67M
FPRX
60
PUT
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$2.61M 0.47%
+50,000
New +$2.39M
XLRN
61
DELISTED
Acceleron Pharma
XLRN
$2.53M 0.45%
70,000
+20,000
+40% +$663K
MGNX icon
62
MacroGenics
MGNX
$255M
$2.39M 0.43%
80,000
+5,000
+7% +$149K
BSX icon
63
Boston Scientific
BSX
$74.3B
$2.38M 0.42%
100,000
– –
GILD icon
64
CALL
Gilead Sciences
GILD
$170B
$2.37M 0.42%
+30,000
New +$2.44M
THC icon
65
Tenet Healthcare
THC
$21.3B
$2.27M 0.4%
100,000
-50,000
-33% -$1.3M
ADMA icon
66
ADMA Biologics
ADMA
$2.22B
$2.17M 0.39%
300,000
+175,000
+140% +$1.11M
ADAP
67
DELISTED
Adaptimmune Therapeutics
ADAP
$2.12M 0.38%
300,000
+100,000
+50% +$763K
IMMU
68
DELISTED
Immunomedics Inc
IMMU
$1.95M 0.35%
600,000
+375,000
+167% +$1.05M
CCXI
69
DELISTED
ChemoCentryx, Inc.
CCXI
$1.81M 0.32%
300,000
+150,000
+100% +$709K
PRAH
70
DELISTED
PRA Health Sciences, Inc.
PRAH
$1.7M 0.3%
+30,000
New +$1.47M
ACAD icon
71
Acadia Pharmaceuticals
ACAD
$5.13B
$1.59M 0.28%
+50,000
New +$1.7M
ONCE
72
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$1.5M 0.27%
25,000
-35,000
-58% -$2.02M
EPZM
73
DELISTED
Epizyme, Inc
EPZM
$1.48M 0.26%
150,000
-50,000
-25% -$456K
ESPR
74
PUT
DELISTED
Esperion Therapeutics
ESPR
$1.39M 0.25%
+100,000
New +$1.13M
ESPR
75
DELISTED
Esperion Therapeutics
ESPR
$1.11M 0.2%
+80,000
New +$907K
1 2
3
4 5

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q3 2016 Portfolio in Review

As of Q3 2016, Iguana Healthcare Management held 112 positions worth $561M, up 128% from $246M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Iguana Healthcare Management deployed $248M of net new capital in Q3 2016, opening 30 new positions and adding to 42 existing holdings. Its largest new stake was Bristol-Myers Squibb: 130,000 shares worth $7.01M.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets, down from 78% a quarter earlier, followed by Energy.

On the sell side, the largest reduction was Elevance Health, an estimated $2.58M trimmed.

  • Iguana Healthcare Management's largest Q3 2016 buy was Bristol-Myers Squibb: 130,000 shares worth $7.01M.
  • Iguana Healthcare Management added most to Ultragenyx Pharmaceutical in Q3 2016, an estimated $16.6M increase.
  • Iguana Healthcare Management's biggest Q3 2016 reduction was Elevance Health, cutting an estimated $2.58M.
  • Iguana Healthcare Management fully exited Baxter International in Q3 2016, selling an estimated $6.11M.
  • Iguana Healthcare Management's ten largest holdings make up 35% of its $561M portfolio in Q3 2016.
  • Iguana Healthcare Management opened 30 new positions and closed 33 in Q3 2016.
  • Iguana Healthcare Management's portfolio value rose 128% quarter-over-quarter to $561M.

Based on Iguana Healthcare Management's 13F filing for Q3 2016, filed 14 Nov 2016.